These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1615637)

  • 1. The effect of oxytetracycline treatment on immunity induced by Anaplasma centrale.
    Pipano E; Krigel Y; Markovics A; Shkap V
    Vet Microbiol; 1992 Apr; 31(1):81-7. PubMed ID: 1615637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of long-acting oxytetracycline in the immunisation of cattle against Babesia bovis and B bigemina.
    Pipano E; Markovics A; Kriegel Y; Frank M; Fish L
    Res Vet Sci; 1987 Jul; 43(1):64-6. PubMed ID: 3628985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with Anaplasma centrale: response after an experimental challenge with Anaplasma marginale.
    Anziani OS; Tarabla HD; Ford CA; Galleto C
    Trop Anim Health Prod; 1987 May; 19(2):83-7. PubMed ID: 3629722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response and hematologic evaluation of pregnant Jersey cows after vaccination with Anaplasma centrale.
    Meléndez RD; Toro Benítez M; Niccita G; Moreno J; Puzzar S; Morales J
    Vet Microbiol; 2003 Jul; 94(4):335-9. PubMed ID: 12829387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of antigenic differences that discriminate between cattle vaccinated with Anaplasma centrale and cattle naturally infected with Anaplasma marginale.
    Molloy JB; Bock RE; Templeton JM; Bruyeres AG; Bowles PM; Blight GW; Jorgensen WK
    Int J Parasitol; 2001 Feb; 31(2):179-86. PubMed ID: 11239938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
    Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frozen and fresh Anaplasma centrale vaccines in the protection of cattle against Anaplasma marginale infection.
    Abdala AA; Pipano E; Aguirre DH; Gaido AB; Zurbriggen MA; Mangold AJ; Guglielmone AA
    Rev Elev Med Vet Pays Trop; 1990; 43(2):155-8. PubMed ID: 2092348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new long-acting oxytetracycline formulation against anaplasmosis in colombian cattle.
    Todorovic RA; Gonzalez EF; Garcia O
    Tropenmed Parasitol; 1979 Jun; 30(2):236-8. PubMed ID: 483386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a short and a long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves.
    Stewart CG; Immelman A; Grimbeek P; Grib D
    J S Afr Vet Assoc; 1979 Jun; 50(2):83-5. PubMed ID: 551196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectivity virulence and immunogenicity of Anaplasma centrale live blood vaccine.
    Potgieter FT; Van Rensburg L
    Onderstepoort J Vet Res; 1983 Mar; 50(1):29-31. PubMed ID: 6348636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of vaccine-induced immunity to anaplasmosis without induction of persistent postvaccinal complement-fixing and agglutinating antibodies in yearling steers.
    Corrier DE; Johnson JS; Wagner GG
    Am J Vet Res; 1985 Mar; 46(3):583-6. PubMed ID: 3994127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of an attenuated Anaplasma marginale vaccine in Mexico natural challenge of immunity in an enzootic area.
    Osorno MB; Solana PM; Perez JM; Lopez TR
    Am J Vet Res; 1975 May; 36(5):631-3. PubMed ID: 1137209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous antibody responses of calves to Anaplasma centrale and A. marginale.
    Adams JH; Shiels IA; de Vos AJ
    Vet Parasitol; 1989 Apr; 31(1):7-12. PubMed ID: 2728329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Babesia bigemina, Babesia argentina, and Anaplasma marginale: Coinfectious immunity in bovines.
    Todorovic RA; Gonzalez EF; Adams LG
    Exp Parasitol; 1975 Apr; 37(2):179-92. PubMed ID: 1123013
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic alterations of Anaplasma marginale in calves after treatment with oxytetracycline.
    Simpson CF
    Am J Vet Res; 1975 Oct; 36(10):1443-6. PubMed ID: 1190584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propagation of the Israeli vaccine strain of Anaplasma centrale in tick cell lines.
    Bell-Sakyi L; Palomar AM; Bradford EL; Shkap V
    Vet Microbiol; 2015 Sep; 179(3-4):270-6. PubMed ID: 26210950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.